Literature DB >> 3094938

Branch specificity of beta-D-galactosidase from Escherichia coli.

D H van den Eijnden, W M Blanken, A van Vliet.   

Abstract

The "branch specificities" of the beta-D-galactosidases from Escherichia coli, jack bean, Aspergillus niger, and human liver were investigated with two branched oligosaccharide substrates, one which forms part of a complex-type biantennary N-linked glycan (compound 1) and a structure having blood group I activity (compound 2), respectively. Both substrates were available as radioactive compounds having a known distribution of 3H and 14C label in each of the terminal galactosyl groups, which allowed accurate estimation of the branch specificity of the enzymes from the ratio of 3H and 14C radioactivity in the galactose released by these hydrolases. It was found that the beta-D-galactosidase from E. coli preferentially released the galactosyl group at the 1----3 branch of compound 1 and that the 1----6 branch of compound 2. By contrast, the other beta-D-galactosidases investigated showed little or no branch specificity. These results suggest that the branch specificity of the beta-D-galactosidase from E. coli has to be explained from a specific recognition of certain parts of the aglycon of the substrates by this enzyme rather than from a better accessibility of the galactose at one particular branch.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094938     DOI: 10.1016/s0008-6215(00)90352-5

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  7 in total

1.  An enzymatic strategy to asymmetrically branched N-glycans.

Authors:  Angie D Calderon; Jun Zhou; Wanyi Guan; Zhigang Wu; Yuxi Guo; Jing Bai; Qing Li; Peng George Wang; Junqiang Fang; Lei Li
Journal:  Org Biomol Chem       Date:  2017-09-13       Impact factor: 3.876

2.  Synthesis of Gal beta 1-3GlcNAc and Gal beta 1-3GlcNAc beta-SEt by an enzymatic method comprising the sequential use of beta-galactosidases from bovine testes and Escherichia coli.

Authors:  L Hedbys; E Johansson; K Mosbach; P O Larsson; A Gunnarsson; S Svensson; H Lönn
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

3.  Construction of linear GlcNAc beta 1-6Gal beta 1-OR type oligosaccharides by partial cleavage of GlcNAc beta 1-3(GlcNAc beta 1-6)Gal beta 1-OR sequences with jack bean beta-N-acetylhexosaminidase.

Authors:  O Renkonen; R Niemelä; A Leppänen; H Maaheimo; A Seppo; L Penttilä; A Vilkman
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

4.  Characterizing human α-1,6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases.

Authors:  Bhargavi M Boruah; Renuka Kadirvelraj; Lin Liu; Annapoorani Ramiah; Chao Li; Guanghui Zong; Gerlof P Bosman; Jeong-Yeh Yang; Lai-Xi Wang; Geert-Jan Boons; Zachary A Wood; Kelley W Moremen
Journal:  J Biol Chem       Date:  2020-10-01       Impact factor: 5.157

5.  Streamlining the chemoenzymatic synthesis of complex N-glycans by a stop and go strategy.

Authors:  Lin Liu; Anthony R Prudden; Chantelle J Capicciotti; Gerlof P Bosman; Jeong-Yeh Yang; Digantkumar G Chapla; Kelley W Moremen; Geert-Jan Boons
Journal:  Nat Chem       Date:  2018-12-10       Impact factor: 24.427

Review 6.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

7.  The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.

Authors:  H Kemperman; Y Wijnands; J Wesseling; C M Niessen; A Sonnenberg; E Roos
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.